|
| 1 | TABLET, BETHANECOL CHLORIDE 50 MG |
| 2 | TABLET,CYPROTERONE ACETATE 2mg + ETHINYL OESTRADIOL 0.035mg |
| 3 | TABLET,DEFERASIROX 400mg DISPERSABLE |
| 4 | TABLE, DEHYDROEPIANDROSTERONE SR 75 MG, MICRONIZED |
| 5 | TABLET,DOXAZOSIN 2mg |
| 6 | TAB. DROSPERINON 3MG + ETHINYLESTRADIOL 0.02MG |
| 7 | TABLET,GRISEOFULVIN 250mg |
| 8 | TABLET,IBUPROFEN 400mg + PARACETAMOL 325mg + CHLORZOXAZONE 250mg |
| 9 | TABLET,ISONIAZID,100 mg + RIFAMPICIN 100 mg |
| 10 | ISONIAZID 300 MG+VIT.B6 TAB |
| 11 | LEVONERGESTROL 0.1 MG + ETHINYLESTRADOIL 0.02 MG |
| 12 | LEVONORGESTRAL 0.1mg +ETHINYKESTRADIOL 0.02 MG TAB |
| 13 | CAPSULE,MULTIVITAMIN AND MINARALSCOMPOSITION VITAMIN A 5000 IU AS VITAMIN A CONCENTRATE-OILYFROM IP,VITAMIN D3 CHOLECALCIFEROL IP 400IU,VITAMIN E TOCOPHERYLACETATE IP 15mg,VITAMIN B1 IP 5mg,VITAMIN B2 IP 5mg,NICOTINAMIDEIP 45mg D-PANTHENOL IP 5 MG, VITAMIN B6 IP 2 MG, VITAMIN C IP 75 MG,FOLIC ACID IP 1000 MCG, VITAMIN B12 IP 5 MCG, DIBASIC CALCIUMPHOSPHATE IP 70 MG, COPPER SULPHATE BP 0.1 MG. MANGANESESULPHATE MONOHYDRATE BP 0.01 MG, ZINC SULFATE MONOHYDRATE USP28.7 MG ( EQUIVALENT TO 10.4 MG OF ELEMENTAL ZINC ), POTASSIUMLODIDE IP 0.025 MG, LIGHT MAGNESIUM OXIDE IP 0.15 MG. BOTT OF 30 CAPS |
| 14 | TABLET,ORMELOXIFENE 60 mg |
| 15 | TABLET, PHENAZOPYRIDINE 200 MG |
| 16 | TAB, POTASSIUM CITRATE, 1080 MG |
| 17 | TAB. PRAMIPEXOLE ER 1.5MG |
| 18 | TAB. SODIUM AMINOSALICYLATE(1000 MG)TAB. |
| 19 | TABLET, SUMA TRIPTAN, 25 MG |
| 20 | TABLET,TAMOXIFEN CITRATE 10mg |
| 21 | TABLET,TOLTERADINE TARTRATE ER 4mg |
| 22 | TABLET,TRIAMETERENE 50mg + BENZYTHIAZIDE 25mg |
| 23 | TAB. TRIFLUOPERAZINE 1MG |
| 24 | TABLET VITAMIN A-50,000 IU |
| 25 | VITAMIN D3,1000 IU |
| 26 | CAPSULE,AMANTADINE 100mg |
| 27 | CAPSULE, DEXLANSOPRAZOLE, 60 MG |
| 28 | CAPSULE,FENOFIBRATE 200mg |
| 29 | PATCH, FENTANYL PATCH 12 UG/HR |
| 30 | CAPSULE,GEMFIBROZIL 300mg |
| 31 | CAPSULE,RIFAMPICIN 150mg |
| 32 | CAPSULE,RIVASTIGMINE 4.5mg |
| 33 | CAPSULE,RIVASTIGMINE 6mg |
| 34 | RIVASTIGMINE TRANSDERMAL SYSTEM 5 (CONTAINS 9 MG) |
| 35 | PATCH,RIVASTIGMINE TRANSDERMAL SYSTEM 10,(CONTAINING18mg) |
| 36 | PATCH,RIVASTIGMINE TRANSDERMAL SYSTEM 15,CONTAINS 27mg |
| 37 | CAPSULE, RIFABUTIN, 150 MG |
| 38 | CAP, SOYA ISOFLAVONE 60 MG, BLACK COHOSH 40 MG, MILK CALCIUM 250 MG, VIT D3 200 IU, MAGNESIUM 50 MG |
| 39 | CAP. ZIPRASIDONE 40MG |
| 40 | DROP, 2% ACETIC ACID, EAR |
| 41 | DROP, CHLORAMPHENICOL I.P 5% W/V + BECLOMETHASONE DIPROPIONATE I.P 0.025% W/V +CLOTRIMAZOLE I.P 1% W/V +WITH/WITHOUT LIGNOCAINE HCL I.P MINIMUM 1.73% W/V |
| 42 | FLUTICASONE PROPRIONATE 0.5%+BENZALKONIUM HCL NF 0.01%+PRENYLETHYLALCORD 0.25% 100/150 METERED DOSE NASAL SPRAY |
| 43 | ISOTONIC NASAL SPRAY (SODIUM CHLORIDE IP 0.9% W/V IN PURIFIED WATER IP) |
| 44 | EYE GEL (HYDROXY PROPLY METHYCELLULOSE) HPMC 0.3+ carbomer 980 (2.2 mg) |
| 45 | DROP EYE ,PILOCARPINE NITRATE 2%, |
| 46 | TRAVOPROST 0.004% + TIMOLOL MALEATE 0.5% EYE DROPS PRESERVATIVE FREE, BOTTLE OF 5 ML METERED DOSE PACK |
| 47 | INTRAVENOUS AMINOACID 10%(CONTAINS 21 TYPES OF AMINOACID) BOTT/100 ML |
| 48 | INJECTION,ATRACURIUM 5mg/ml,2.5ml/AMP |
| 49 | INJECTION,BUPRENORPHINE 0.3mg,1ml/AMP |
| 50 | INJECTION,CIPROFLOXACINE I.V (200mg),100ml/BOTTLE |
| 51 | INJECTION,CLOXACILLIN SODIUM 250mg |
| 52 | INJECTION,DEPOT MEDROXYPROGETRONE ACETATE 150mg |
| 53 | DEXTROSE 25% I.V BOTT.OF 100ML/BOTTLE WITH CAP |
| 54 | INJECTION,DEXTROSE 5% IV,500ml/BOTTLE WITH CAP |
| 55 | INJECTION,DEXTROSE 5%+ SODIUM CHLORIDE 0.9%,500ml/BOTTLE WITH CAP |
| 56 | DISTILLED WATER,INJECTION,5ml/AMP |
| 57 | EPHIDRINE HCL 30mg/ml,AMP OF 1ml |
| 58 | INJECTION,FENTANYL CITRATE 50mcg/ml,2ml |
| 59 | INJ. FLUCONAZOLE 200 MG/VIAL |
| 60 | ( INTRAVENOUS COLLOID ) 4 % SUCCINYLATED GELATINE SOLUTION , 500ML |
| 61 | INJECTION,GLYCERYL TRINITRATE,25mg,NITROGLYCERINE |
| 62 | HYALURONIDASE (1500 IU)INJ AMP OF 1ML |
| 63 | COLLOIDAL INFUSION SOLUTION OF 3.5% POLYGELINE, 500ML |
| 64 | INJECTION,INTRAVENOUS FAT EMULSION 20% (FOUR TYPES OF LIPID) 20% INTRALIPID 1000ml OF EMULSION CONTAINS-PURIFIED SOYABEAN OIL 200mg, PURIFIED EGG PHOSPHOLIPID, GLYCEROL ANHYDROUS SODIUM HYDROXIDE & WATER FOR INJECTIONS,100ml/BOTTLE |
| 65 | INJECTION,CONCENTRATED R-LACTATED R-LACTRATE SOLUTION FOR INJECTION,AMPOULE OF 20 ML,AFTER 25 TIMES DILUTION EACH 100 ML SOLUTION CONTAIN-SODIUM 13.1mmol(EQUIVALENT TO 3275 mmol/l)+ POTASIUM 0.5 mmol(EQUIVALENT TO 125mmol/l)+CHLORIDE 11.1mmol(EQUIVALENT TO 2775 mmol/l)+ CALCIUM 0.2mmol(EQUIVALENT TO 725 /l) |
| 66 | INJECTION OF MECOBALAMIN, PYRIDOXINE HYDROCHLORIDE AND NICOTINAMIDE, AMP. OF 2 ML. EACH 2 ML AMP. CONTAINS : MECOBALAMIN JP 1000 MCG, PYRIDOXINE HYDROCHLORIDE IP 100 MG, NICOTINAMIDE IP 100 MG, BENZYL ALCHOHOL IP 2% w/v (AS PRESERVATIVE), WATER FOR INJECTION IP Q.S. |
| 67 | INJECTION,MENADIONE SODIUM BISULPHITE IP 10mg/ml AMP OF 1ml |
| 68 | INJECTION,OFLOXACIN 400 MG |
| 69 | INJECTION, TOTAL PARENTRAL NUTRITION (1500ml-2000ml) COMPOSITION:(AMINO ACIDS, ELECTROLYTES, DEXTROSE AND LIPID EMULSION IN A 3 CHAMBER BAG) |
| 70 | INJECTION, PERFLUTREN LIPID MICROSPHERE INJECTABLE SUSPENSION, 2 ML |
| 71 | INJECTION,RINGER ACETATE,BALANCED CRYSTALLOID SOLUTION 500 ML BAG |
| 72 | INJECTION,ROPIVACAINE HYDROCLORIDE 0.5%,10ml AMP,PRESERVATIVE FREE |
| 73 | INJECTION,ROPIVACAINE HCL HEAVY 0.75%, 4ml AMP |
| 74 | INJECTION,SODIUM CHLORIDE 0.9% IV,500ml/BOTTLE WITH CAP |
| 75 | INJECTION,SODIUM CHLORIDE 0.9% W/V,3 l/BOTTLE WITH CAP |
| 76 | INJECTION SODIUM CHLORIDE 3% NA-513 MEQ/L, CL-513 MEQ/L, BOTTLE OF 100 ML |
| 77 | INJECTION,SODIUM CHLORIDE IP 0.9% IV,1l/BOTTLE WITH CAP |
| 78 | INJECTION, SODIUM CHLORIDE (0.9%) 100ML IN COLLAPSIBLE BAG |
| 79 | INJECTION,RINGER LACTATE,500ml/BOTTLE WITH CAP |
| 80 | INJECTION, SODIUM CHLORIDE INTRAVENOUS BP 0.45% W/V CONTAINING SODIUM 75mmol/l + CHLORIDE 75mmol/l, BOTTLE OF 500ml |
| 81 | INJECTION, SODIUM CHLORIDE INTRAVENOUS BP 0.45% W/V AND 5% DEXTROSE INJECTION CONTAINING SODIUM 75mmol/l + CHLORIDE 75mmol/l + DEXTROSE 50g/l, BOTTLE OF 500ml. |
| 82 | VIT.A I.P.1000 iu ,CHOLECALCIFEROL I.P.100 iu, ALPHATOCOPHERYL ACETATE 0.50MG. THIAMINE HCL I.P.5 MGPYRIDOXINE HCL I.P. 1.50MG RIBOFLAVINESODIUM PHOSPHATE I.P. 1.40 MGASCORBIC ACID I.P. 50 MG ,NICOTINAMIDE I.P.10MG, D-PANTHOL I.P.2.50MG BENZYLALCOHOL 1%, W/V |
| 83 | INJECTION,ZUCLOPENTHIXOL DECANOATE BP 200mg + FRACTIONATED COCONUT OIL |
| 84 | CAPSULE,BECLOMETHASONE DIPROPIONATE ROTACAP 200mcg,30/BOTTLE |
| 85 | CAPSULE,IPRATROPIUM BROMIDE 40mcg + SALBUTAMOL SULPHATE ROTACAP 200mcg,30/BOTTLE |
| 86 | INHALER SALMETROL 25 MCG + FLUTICASONE PROPIONATE IP 50 MCG BOTT OF 120 METERED DOSE |
| 87 | PARAFFIN LIQUID BP/IP,400/450ml/BOTTLE |
| 88 | JELLY,YELLOW PETROLEUM I.P,100gm/TIN |
| 89 | ADAPALENE GEL 0.1%W/W TUBE OF 15GM |
| 90 | ALODERM CREAM 50 GM |
| 91 | CREAM, BENZOYL PEROXIDE, 4 % W/W |
| 92 | CREAM,BETAMETHASONE DIPROPIONATE 0.05% W/W + CALCIPOTRIOL HYDRATE 0.005% w/w TUBE OF 15GM |
| 93 | CREAM,BETAMETHASONE DIPROPIONATE 0.05 W/ W MICONAZOLE NITRATE 2% + GENTAMYCIN SULPHATE 0.1%,Tube of MINIMUM 20 gm |
| 94 | CREAM,BETAMETHASONE VALERATE EQUIVALENT TO BETAMETHASONE 0.10 % W/W + SALICYLIC ACID (3.0%),20g/TUBE |
| 95 | OINTMENT,BECLOMETHASONE DIPROPIONATE (0.025%) SALICYLIC ACID (3.00%) UREA 10%,LACTIC ACID 3.00%,20g/TUBE |
| 96 | CHLOROMYCETIN APPLICAPS FOR LOCAL OPHTHALMIC USE |
| 97 | CREAM, CLOBETASOLPROPIONATE 0.05% W/W + GENTAMICIN 0.1% W/W |
| 98 | CLOTRIMAZOLE IN PROPYLENE GLYCOL AND GLYCERINE BASE 1% |
| 99 | OINTMENT,CROTAMITON 10%W/W,20g/TUBE |
| 100 | GEL,DINOPROSTONE 0.5mg |
| 101 | CREAM,ESTRIOL 15g |
| 102 | CREAM,FLUOCINOLONE ACETONIDE 0.025%,20g |
| 103 | FLUOCINOLONE ACETONIDE CREAM 0.1% TUBE OF 30 GMS |
| 104 | CREAM,FRAMYCETIN SULPHATE 1% W/W,30g/TUBE |
| 105 | GATIFLOXACIN EYE OINTMENT, TUBE OF 5GM |
| 106 | HYDROCORTISONE TENDRON 0.50% CREAMTUBE OF 15 GMS |
| 107 | CREAM,HYDROQUINONE 2%,OXYBENZONE2.5%,OCTINOXATE 9%,30g |
| 108 | KETOROLAC TROMETHAMINE 2%W/W + ETHANOL 5% W/W |
| 109 | JELLY,LUBRICATING,STERILISED,50g/TUBE |
| 110 | METRONIDAZOLE GEL 1.5% W/W, METRONIDAZOLE BENZOATE IP EQUIVALENT TO METRONIDAZOLE 1.5% W/W, CHLORHEXIDINE GLUCONATE SOLUTION IP 0.5% W/W (AS PRESERVATIVE) WATER SOLUBLE GEL BASE Q.S., TUBE OF 20 GM |
| 111 | GEL, METRONIDAZOLE 2% W/W |
| 112 | NEOMYCIN AND POLYMYCIN B SULPHATES AND BACITRACIN ZINC OPTHALMIC OINTMENT TUBE OF 5 GMS |
| 113 | GEL,PIROXICAM BP 0.5% W/W,30g/TUBE |
| 114 | CREAM,SALICYCLIC ACID 6% W/W,30g/TUBE |
| 115 | TRETINOIN 0.025% CREAM TUBE OF MINIMUM 20 GM |
| 116 | TUBE, ZINC OXIDE 10% W/W + CETYLATED FATTY ESTER COMPLEX 0.6% W/W + D-PANTHENOL 1.0% W/W TUBE OF 30 GMS. |
| 117 | SYRUP,DL-METHIONINE BP 100mg,CHOLINE DIHYDROGEN CITRATE NFXII 100mg,L-ISOLEUCINE USP 10mg,L-LEUCINE USP 19mg,L-VALINE USP 11mg,PYRIDOXINE HYDROCHLORIDE IP 1.50mg,NICOTINAMIDE IP 22.5mg,BIOTIN USP 10mg,FOLIC ACID 0.5mg,CYNOCOBALAMINE IP 3mcg,INOSITOL 50mg,200ml/BOTTLE |
| 118 | SYRUP,HALOPERIDOL,30ml/BOTTLE |
| 119 | SOLUTION,SODIUM VALPROATE 200mg/5ml,100ml/BOTTLE |
| 120 | SUPPOSITORY,DICLOFENAC 12.5mg |
| 121 | CREAM,HYDROCORTISONE ACETATE FOAM 10 % W/W |
| 122 | LEVONORGESTREL INTRAUTERINE SYSTEM |
| 123 | LEVONOGESTREL 52 MG INTRAUTRINE DEVICE |
| 124 | SOLUTION, MESALAMINE RECTAL SUSPENSION 4 GM/60 ML |
| 125 | SALINE,ORAL,LAXATIVE,45ml X 2 BOTTLE PACKING,EACH 45ml SHOULD CONTAIN MINIMUM STRENGTH /QUANTITY IN EACH OF THE FOLLOWING: MONOBASIC SODIUM PHOSPHATE DIHYDRATE USP 24.417g , DISODIUM HYDROGEN PHOSPHATE DIHYDRATE BP 5.439g, SODIUM BENZOATE IP (AS PRESERVATIVE) 0.2% W/V EXCEPIENTS QS |
| 126 | SOLUTION,PROCTO-CLYSIS ENEMA,100ml/PACK,CONTAINING MINIMUM STRENGTH/QUANTITY IN EACH OF THE FOLLOWING: SODIUM ACID PHOSPHATE I.P 10% W/V, SODIUM PHOSPHATE I.P 8% W/V |
| 127 | INJECTION,ANTI-D IMMUNOGLOBULIN 300mcg/ml |
| 128 | INJECTION,CARBOPROST TROMETHAMINE 125mcg/ml,AMP OF 1ml |
| 129 | INJECTION,DIPHTHERIA,PERTUSSIS&TETANUS VACCINE 0.5ml |
| 130 | RECOMBINANT, THERMOSTABLE (UPTO 25 C), LIQUID GROWTH HORMONE, 30IU IN A PREFILLED MULTIDOSE PEN. |
| 131 | INJECTION MIXTURE OF INSULIN ASPART & PROTAMIN. (ONE COMPATIABLE PEN SHALLBE PROVIDED BEHIND EVERY 30 CARTRIDGES) |
| 132 | INJECTION, PORACTANT ALFA 120mg / 1.5ml |
| 133 | INJECTION, PORACTANT ALFA 240mg / 3ml |
| 134 | INJECTION, RECURONIUM BROMIDE VIAL OF 10ml |
| 135 | INJECTION,SOMATROPIN 36iu 12mg |
| 136 | INJECTION,OCTREOTIDE 20 MG/ML |
| 137 | INJ. LUPROLIDE ACETATE 4MG/4ML |
| 138 | INJECTION, CENTRORELIX ACETATE 0.25mg |
| 139 | INSULIN, DEGLUDEC (2.56 MG) + INSULIN ASPART (1.05 MG) (PREFILLED SYRING OF 100 TUS/ML) |
| 140 | INJ. LEUPROLIDE ACETATE DEPOT SUSPENSION 11.25MG |
| 141 | INJECTION,PURIFIED VI-CAPSULAR POLYSACCHARIDE OF S TYPHI TY2 CONJUGATED TO TETANUS TOXOID-25 MCG |
| 142 | INJECTION, TUROCTOCOG ALFA PEGOL-1000 IU |
| 143 | INJECTION, DIPTHERIA TOXOID MORE THAN 20IU, TETANUS TOXOID MORE THAN 40IU, BORDETELLA PERTUSSIS ANTIGEN (TOXOID / FILAMENTOUS HAEMGGLUTININ) 25/25 MCG, HEMOPHILOUS INFLUENZA-TYPE B POLYSACCHARIDE CONJUGATED TO TT 12 MCG, INACTIVATED POLIO VIRUS VACCINE (TYPE1-40D, TYPE-2-8D, TYPE-3-32D ANTIGEN UNIT), PFS, 0.5 ML |
| 144 | INJECTION, EACH PFS OF 0.5 ML SHOULD CONTAIN DIPTHERIA TOXOID MORE THAN 20IU, TETANUS TOXOID MORE THAN 40IU, BORDETELLA PERTUSSIS ANTIGEN (TOXOID / FILAMENTOUS HAEMGGLUTININ) 25/25 MCG, INACTIVATED POLIO VIRUS VACCINE (TYPE -40D, TYPE-2-8D, TYPE-3-32D ANTIGEN UNIT) |
| 145 | INJECTION,PNEUMOCCOCAL POLYSACCHARIDE VACCINE 0.5ml, EACH 0.5ml SINGLE DOSE OF VACCINE CONTAINS 25mcg POLYSACCHARIDE OF EACH OF 12 PNEUMOCOCCAL SEROLYPES AND PHENOL AS A PRESERVATIVE 0.25% W/V CY IM.5% SODIUM CHLORIDE 0.9% W/V WATER FOR INJ Q.S, TOTAL AMOUNT OF POLYSACCHARIDE PER VIAL = 862.5mcg/0.75ml |
| 146 | INJECTION, EXTENDED HALF-LIFE RECOMBINANT FACTOR-8-1500IU |
| 147 | PESSARY, DINOPROSTONE 10 MG (1 VAGINAL PESSARY) |
| 148 | TABLET,MORPHINE SULPHATE,10mg |
| 149 | PATCH, BUPRENORPHINE TRANSDERMAL 10MG |
| 150 | INJECTION,NALBUPHINE HYDROCHLORIDE 10mg/ml |
| 151 | INJECTION, PHENYLEPHRINE, 50MCG |
| 152 | GEL, BENZOCAINE 20 % |
| 153 | CAPSULE, CAROVERINE, 20 MG |
| 154 | DROP,BETAMETHASONE SODIUM PHOSPHATE 0.1% + NEOMYCIN SULPHATE 0.5% |
| 155 | TABLET,REBAMIPIDE 100MG |
| 156 | TABLET METRONIDAZOLE 400MG+DILOXANIDE FUROATE 500 MG + Simethicone 100mg |
| 157 | CAPSULE,FLUTICASONE PROPIONATE ROTACAP 100mcg,30/BOTTLE |
| 158 | SYRUP,FERROUS CALCIUM CITRATE COMPLEX 500mg + IRON 25mg + CALCIUM 85mg + FOLIC ACID IP 0.3mg,200ml/BOTTLE |
| 159 | INJECTION,DEXTROSE 10% IV,500ml/BOTTLE |
| 160 | INJECTION, DEXTROSE 5% I.V, BOTT.OF 250ML |
| 161 | INJECTION, MULTIPLE ELECTROLYTE(ISOLYTE-P IV), BOTTLE OF 250ML |
| 162 | INJECTION, MULTIPLE ELECTROLYTE(ISOLYTE-P IV), BOTTLE OF 500ML |
| 163 | INJECTION, PRALIDOXIME CHLORIDE IP 500MG |
| 164 | TABLET,DESOGESTREL B.P 75mcg |
| 165 | TABLET,ESTROGEN-CONJUGATED 0.3mg |
| 166 | TABLET,RALOXIFENE 60mg |
| 167 | CAPSULE,AMINO ACID AND VITAMINCOMPOSITION L-LEUCINE USP 18.3mg,L-ISOLEUCINE USP 5.8mg,L-LYSINE HYDROCHOLORIDE USP 25mg,L-PHENYLALANINE USP 5 mg,L-THREONINE USP 4.2mg,L-VALINE USP 6.7mg,L-TRYPTHOPHAN USP 5mg+DL-METHIONIN USP XXI 18.4mg + 6-HYDROXY ANTHRANILIC ACID HYDROCHLORIDE 0.2mg + VITAMIN A CONCENTRATE I.P 2500 I,U (POWDER FORM ) CHOLECALCIFEROL I.P 200 I.U + THIAMINE MONONITRATE I.P 5mg + RIBOFLAVINE I.P 3mg + NICOTINAMIDE I.P 25mg + PYRIDOXINE HYDROCHLORIDE I.P 1.5mg + FOLIC ACIDI.P 0.75mg + CALCIUM PANTOTHENATE I.P 5mg + CYANOCOBALAMIN I.P 2.5mg + ASCORBIC ACID I.P 40mg + TOCOPHERYL ACETATE I.P 7.5 I.U COLUR USED TARTRAZINE,ERYTHROSINE,INDIGO CARMINE SUNSET YELLOW FCF AND TITANIUM DIOXIDE |
| 168 | CAPSULE,CITROUS BIOFLAVONOID 150mg + ASCORBIC ACID 75mg + MENADIONE I.P 0.66mg + FERROUS GLUCONATE I.P 67mg + TRIBASIC CALCIUM PHOSPHATE 144.43mg |
| 169 | CAPSULE,MULTI VITAMIN & MINERALS,VIT A 2500 IU, VIT E 30mg + VIT D3 100 IU + VIT B1 10mg + VIT B2 5mg + VIT B6 250mg + VIT B12 9mcg + VIT C 45mg + FOLIC ACID 400mcg + NIACINAMIDE 20mg + CALCIUM PANTOTHENATE 30mg +BIOTIN 30mcg + PARAAMINO BENZOIC ACID(PABA)BP 30mg + IRON 12mg + ZINC 15mg + COPPER 1mg + MANGANESE 2mg + MAGNESIUM 100mg + IODINE 225mcg + CROMIUM 50mcg + SELENIUM 100mcg + BORON 2mg BETACAROTINE 30mg,10/STRIP |
| 170 | CAPSULE,ULIPRISTAL,5mg |
| 171 | CLINDAMYCIN 100mg + CLOTRIMAZOLE 100mg VAGINAL SUPPOSITORY |
| 172 | INJECTION, TRIPTORELIN ACETATE, 0.1 MG, 1 ML PFS |
| 173 | INJ. ETHAMSYLATE 250 MG |
| 174 | SOLUTION, FERACRYLUM 1%, 100ML |
| 175 | TABLET, METAPROTERENOL (ORCIPRENALINE) |
| 176 | TABLET, FRUSEMIDE, 100 MG |
| 177 | TABLET,LEUCOVORIN(15 MG) |
| 178 | TABLET SOTALOL 40 MG |
| 179 | TABLET PROPAFENONE 150 MG |
| 180 | TABLET, APREMELAST, 10MG |
| 181 | CAPSULE, CLOFAZIMINE, 100 MG |
| 182 | CAPSULE, HYDROXYUREA, 500 MG |
| 183 | OINTMENT,METHOXSALEN HCL 0.75% & AMINOBENZOIC ACID 2% |
| 184 | CREAM, HYDROCORTISONE 0.25% W/W + CROTAMITON 10% W/W |
| 185 | CREAM, FLUTICASONE PROPIONATE 0.05% W/W |
| 186 | SYRUP, GLYCEROL IP 85%, 500 GMS |
| 187 | POWDER,NEOMYCIN SULPHATE IP 3400 UNIT,POLYMYCIN B SULPHATES USP 5000 UNIT,BACITRACIN ZINC IP 400 UNIT,ANTIBIOTIC POWDER,10g/BOTTLE |
| 188 | SODIUM AMINOSALICYLATE GRANULES I.P.100MG |
| 189 | INJECTION, GRANISETRON 3MG/3ML |
| 190 | INJECTION,CYCLOPHOSPHAMIDE 500mg |
| 191 | INJECTION, ERENUMAB, 70MG/ML, PREFILLED SYRINGE OF 1 ML |
| 192 | TABLET GLIPIZIDE 2.5 MG SUSTAINED RELEASE |
| 193 | OINTMENT, METHOXSALEN & AMINOBENZOIC ACID |
| 194 | PATCH, GLYCERYL TRINITRATE, 5MG |
| 195 | CAPSULE,OPTHALMIC ANTIOXIDANT,CONTAINING MINIMUM STRENGTH/QUANTITY IN EACH OF THE FOLLOWING BETA CAROTENE 6000 IU + COPPER 2mg, GLUTATHIONE 5mg, LUTEIN 3.2mg, MANGANESE 5mg, SELENIUM 40mcg, VITAMIN C 150mg, VITAMIN E 50 IU, ZEAXANTIN 256mcg, ZINC 40mg |
| 196 | DROP, DIFLUPREDNATE OPTHALMIC EMULSION 0.05% |
| 197 | DROP,EYE,SODIUM CROMOGLYCATE 4% |
| 198 | EYE DROP GATIFLOXACIN 0.3% +LOTEPREDNOL ETABONATE 0.5% |
| 199 | OINTMENT, EYE, ATORPINE SULPHATE 1% |
| 200 | DROP EYE TAFLUPROST 0.0015% OPTHALMIC SOLUTION MINIMUM 2.5ML/BOTTLE |
| 201 | INJECTION CYCLOSPORINE 50 MG/ML |
| 202 | CAPSULE, TOCOPHERYL ACETATE 400 MG |
| 203 | CAPSULE,FLUPIRTINE MALEATE 100mg |
| 204 | TABLET,DEFERASIROX 100mg DISPERSABLE |
| 205 | TAB. LEVAMISOLE HYDROCHLORIDE IP 50 MG |
| 206 | TABLET DEXAMETHASONE 4 MG |
| 207 | TABLET ZONISAMIDE - 25 MG |
| 208 | CAPSULE, THALIDOMIDE, 100 MG |
| 209 | SYRUP, CEFIXIME + LACTIC ACID BACILLUS, 50 MG |
| 210 | SYRUP,CHLOROQUINONE,60ml/BOTTLE |
| 211 | SYRUP, SUSPENSION, NALIDIXIC ACID, 300MG/5ML |
| 212 | SYRUP OSELTAMIVIR 12 MG/ML, BOTTLE OF MINIMUM 75 ML |
| 213 | SYRUP, ACEBROPHYLLINE 10MG/ML |
| 214 | INJECTION,DESFERRIOXAMINE 500mg |
| 215 | INJECTION,NORMAL HUMAN IMMUNOGLOBULIN OF WHICH 1 ml SOLUTION WIHOUT ANY PRESRVATIVE SHOULD CONTAIN: 1) PROTEIN 50 mg,OF WHICH ATLEAST 95 % SHOULD BE IMMUNOGLOBULIN (A) IGM 6 mg (B) IGA 6mg (C) IGG-38 mg 2) GLUCOSE MONOHYDRATE 27.5 mg |
| 216 | INJECTION, GnRH AGONIST 1 MG, VIAL OF 2 ML |
| 217 | TABLET ALPRAZOLAM SUSTAINED RELEASE 1.5 MG |
| 218 | TABLET AGOMELATINE 25 MG |
| 219 | TABLET,BUPROPION EXTENDED RELEASE,300 mg |
| 220 | TABLET,IMIPRAMIN HCL 25mg,DIAZEPAM 5mg |
| 221 | TABLET,OXAZEPAM 10mg |
| 222 | TABLET,REMELTEON,8mg |
| 223 | TABLET,MULTIVITAMIN,ANTIOXIDANT AND MINERAL TAB METHYLCOBALAMIN 1500 MCG ALPHA PIPOIC ACID 200 mg,BENFOTIAMINE 150 mg,CHROMIUM POLYNICOTINATE 200 MCG,PYRIDOXINE HCL 3 mg,FOLIC ACID 1.5 mg,INOSITOL 100 mg |
| 224 | TABLET METHYLPHENIDATE 10 MG |
| 225 | TABLET METHYLPHENIDATE 20 MG |
| 226 | TABLET ESZOPICLONE 2 MG |
| 227 | TABLET, ZOLPIDEM, 6.25 MG, SR |
| 228 | TABLET CHLOMIPRAMINE 10 MG |
| 229 | CAPSULE, VENLAFAXINE, ER, 37.5 MG |
| 230 | CAPSULE, ZIPRASIDONE, 20 MG |
| 231 | TABLET,OXYBUTYNINE CHLORIDE 2.5 MG |
| 232 | TABLET,PENTOXYFYLLINE 400mg |
| 233 | TINCTURE,BENZOIN,400/450ml/BOTTLE |
| 234 | CREAM,METRONIDAZOLE WITH WATER SOLUABLE GEL BASE, CONTAINING METRONIDAZOLE 10mg/g W/W,PREFERRED PACK,30g/TUBE |
| 235 | OINTMENT, EYE, AZITHROMYCIN 1%, TUBE OF 5GM Please Enable Macros to View BoQ information |
